125 results
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
5 Jun 24
Registered Number 11185179 (England & Wales) Annual Report and financial statements for the year ended 31 December 2023 for Autolus Therapeutics plc
4:35pm
these cells. We believe our programmed T cell therapies have the potential to be best-in-class and to offer patients substantial benefits over … -term benefits to shareholders of securing the Group’s cash runway through our planned commercial launch of obe-cel, and the positive impact
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
3 Jun 24
Regulation FD Disclosure
5:15pm
studies; the extension of the pipeline beyond obe-cel; expectations regarding the regulatory approval process for any product candidates; the benefits
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
; the extension of the pipeline beyond obe-cel; expectations regarding the regulatory approval process for any product candidates; the benefits
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
benefits over the existing standard of care, including the potential for cure in some patients.
We believe our leadership in T cell programming … product candidates;
the potential benefits of our product candidates;
the timing or likelihood of regulatory filings and approvals for our product
10-K
svt3ap3
21 Mar 24
Annual report
4:55pm
10-K
EX-97.1
s95dtxtpfhlry qxhu
21 Mar 24
Annual report
4:55pm
8-K
zu68tz2ejuvmpl2r
21 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
8-K/A
EX-99.1
euajjz7hnc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
8-K
EX-99.2
z35f3wonb 442sqtwby
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
zfje0n
13 Feb 24
Regulation FD Disclosure
4:06pm
424B5
jtse63 e4fcq1
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
gmw416tj8fhzq 1q1uh
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.2
8xgul144l2zcji
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-99.1
o7gjq8eh2w93o67 cn
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
EX-4.7
ewyo4tub47g6q
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.9
294pmrn368r2pmx3n6
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
rdfsfbyiaq sj
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.10
zjszo
7 Feb 24
Automatic shelf registration
10:00pm
8-K
EX-99.2
gst5pa
11 Dec 23
Regulation FD Disclosure
8:31am